{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:21:47Z","timestamp":1785856907049,"version":"3.56.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":182,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.idcr.2024.e02020","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T07:08:19Z","timestamp":1719904099000},"page":"e02020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Treatment of a challenging NDM and OXA-48-producing Klebsiella pneumoniae causing skin and soft tissue infection and exhibiting resistance to the combination of Ceftazidime-Avibactam and Aztreonam: A case report"],"prefix":"10.1016","volume":"37","author":[{"given":"Thamer A.","family":"Almangour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaida A.","family":"Aldajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alhijji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynaa","family":"Alsharidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2024.e02020_bib1","unstructured":"WHO. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017. Available at: \u3008https:\/\/www.who.int\/news\/item\/27\u201302-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed\u3009. Accessed 05 April 2024."},{"key":"10.1016\/j.idcr.2024.e02020_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad428","article-title":"Infectious diseases society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis: Publ Infect Dis Soc Am"},{"issue":"1","key":"10.1016\/j.idcr.2024.e02020_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12879-022-07507-y","article-title":"Molecular epidemiology and outcome of carbapenem-resistant enterobacterales in Saudi Arabia","volume":"22","author":"Alraddadi","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idcr.2024.e02020_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/IDR.S349004","article-title":"Ceftazidime-avibactam versus colistin for the treatment of infections due to carbapenem-resistant enterobacterales: a multicenter cohort study","volume":"15","author":"Almangour","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.idcr.2024.e02020_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15537\/smj.2018.1.21094","article-title":"The emergence of carbapenem-resistant Klebsiella pneumoniae isolates producing OXA-48 and NDM in the Southern (Asir) province, Saudi Arabia","volume":"39","author":"Al-Zahrani","year":"2018","journal-title":"Saudi Med J"},{"issue":"4","key":"10.1016\/j.idcr.2024.e02020_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jiph.2020.01.003","article-title":"Genomic analysis of the first KPC-producing Klebsiella pneumoniae isolated from a patient in Riyadh: a new public health concern in Saudi Arabia","volume":"13","author":"Alghoribi","year":"2020","journal-title":"J Infect Public Health"},{"issue":"9","key":"10.1016\/j.idcr.2024.e02020_bib7","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/jac\/dkr242","article-title":"Efficacy and safety of tigecycline: a systematic review and meta-analysis","volume":"66","author":"Yahav","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idcr.2024.e02020_bib8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s12325-020-01235-y","article-title":"Effectiveness and safety of high dose tigecycline for the treatment of severe infections: a systematic review and meta-analysis","volume":"37","author":"Zha","year":"2020","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.idcr.2024.e02020_bib9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jac\/dkz532","article-title":"Metallo-\u03b2-lactamase resistance in Enterobacteriaceae is an artefact of currently utilized antimicrobial susceptibility testing methods","volume":"75","author":"Asempa","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idcr.2024.e02020_bib10","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1128\/AAC.02662-14","article-title":"Unexpected in vivo activity of ceftazidime alone and in combination with avibactam against New Delhi metallo-\u03b2-lactamase-producing enterobacteriaceae in a murine thigh infection model","volume":"58","author":"MacVane","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2024.e02020_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.977330","article-title":"Increased zinc levels facilitate phenotypic detection of ceftazidime-avibactam resistance in metallo-\u03b2-lactamase-producing Gram-negative bacteria","volume":"13","author":"Simon","year":"2022","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.idcr.2024.e02020_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad276","article-title":"An NDM-producing escherichia coli clinical isolate exhibiting resistance to cefiderocol and the combination of ceftazidime-avibactam and aztreonam: another step toward pan-\u03b2-lactam resistance","volume":"10","author":"Simner","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.idcr.2024.e02020_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00821-20","article-title":"Struggle To survive: the choir of target alteration, hydrolyzing enzyme, and plasmid expression as a novel aztreonam-avibactam resistance mechanism","volume":"5","author":"Ma","year":"2020","journal-title":"mSystems"},{"issue":"5","key":"10.1016\/j.idcr.2024.e02020_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/jac\/dku568","article-title":"Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam\/avibactam: role of a novel insertion in PBP3","volume":"70","author":"Alm","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idcr.2024.e02020_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jac\/dkz468","article-title":"In vitro selection of aztreonam\/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae","volume":"75","author":"Niu","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idcr.2024.e02020_bib16","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/jac\/dkaa021","article-title":"High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam\/avibactam","volume":"75","author":"Periasamy","year":"2020","journal-title":"J Antimicrob Chemother"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250924000969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250924000969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:15:42Z","timestamp":1741083342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250924000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":16,"alternative-id":["S2214250924000969"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02020","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of a challenging NDM and OXA-48-producing Klebsiella pneumoniae causing skin and soft tissue infection and exhibiting resistance to the combination of Ceftazidime-Avibactam and Aztreonam: A case report","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e02020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02020"}}